Gainers & Losers
Mon Nov 25 2024 10:23:34- Larsen & Toubro share price
- ₹3,753.254.13%
- State Bank Of India share price
- ₹844.753.52%
- HDFC Bank share price
- ₹1,784.602.21%
- Wipro share price
- ₹582.751.99%
- ICICI Bank share price
- ₹1,301.501.82%
Active Stocks
Mon Nov 25 2024 10:27:51- Adani Power share price
- ₹446.85-3.02%
- Power Grid Corporation Of ...
- ₹342.851.74%
- Tata Steel share price
- ₹143.600.56%
- State Bank Of India share price
- ₹844.753.52%
- HDFC Bank share price
- ₹1,784.602.21%
Business News/Market/Market Stats/Suven Pharmaceuticals share price/ Suven Pharmaceuticals Profit Loss Annual
Suven Pharmaceuticals Profit & Loss Annual
Trade1,275.05 -19.30 (-1.49%)Updated : 25 Nov 2024
| Fiscal Period | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
| Revenue | 1,051.35 | 1,340.33 | 1,320.22 | 1,009.72 |
| Total Revenue | 1,051.35 | 1,340.33 | 1,320.22 | 1,009.72 |
| Costof Revenue Total | 448.51 | 568.34 | 550.28 | 415.34 |
| Gross Profit | 602.84 | 771.99 | 769.94 | 594.38 |
| Selling/ General/ Admin Expenses Total | 135.92 | 196.86 | 179.96 | 142.84 |
| Depreciation/ Amortization | 54.60 | 47.73 | 39.10 | 31.64 |
| Other Operating Expenses Total | 61.11 | - | - | - |
| Total Operating Expense | 700.14 | 821.52 | 779.69 | 600.87 |
| Operating Income | 351.22 | 518.81 | 540.53 | 408.84 |
| Interest Inc( Exp) Net- Non- Op Total | -74.51 | 375.32 | 514.67 | 546.79 |
| Other Net | 61.91 | 3.40 | 75.79 | 4.12 |
| Net Income Before Taxes | 405.67 | 559.73 | 667.59 | 467.67 |
| Provisionfor Income Taxes | 105.39 | 148.44 | 213.79 | 105.33 |
| Net Income After Taxes | 300.28 | 411.29 | 453.80 | 362.34 |
| Net Income Before Extra Items | 300.28 | 411.29 | 453.80 | 362.34 |
| Net Income | 300.28 | 411.29 | 453.80 | 362.34 |
| Total Adjustmentsto Net Income | 0.00 | - | 0.00 | - |
| Income Availableto Com Excl Extra Ord | 300.28 | 411.29 | 453.80 | 362.34 |
| Income Availableto Com Incl Extra Ord | 300.28 | 411.29 | 453.80 | 362.34 |
| Diluted Net Income | 300.28 | 411.29 | 453.80 | 362.34 |
| Diluted Weighted Average Shares | 25.45 | 25.46 | 25.46 | 25.46 |
| Diluted EPS Excluding Extra Ord Items | 11.80 | 16.16 | 17.83 | 14.23 |
| Diluted Normalized EPS | 11.80 | 16.16 | 17.83 | 14.23 |
| Research Development | - | 85.86 | 103.55 | 110.58 |
| Gain( Loss)on Saleof Assets | - | -0.07 | -2.01 | 0.34 |
| DPS- Common Stock Primary Issue | - | 1.00 | 2.00 | 2.00 |
*All figures in crores except per share values
Suven Pharmaceuticals Quick Links
Suven Pharmaceuticals Dividend Suven Pharmaceuticals Bonus Suven Pharmaceuticals News Suven Pharmaceuticals AGM Suven Pharmaceuticals Rights Suven Pharmaceuticals Splits Suven Pharmaceuticals Board Meetings Suven Pharmaceuticals Key Metrics Suven Pharmaceuticals Shareholdings Suven Pharmaceuticals Balance Sheet Suven Pharmaceuticals Cashflow Suven Pharmaceuticals Q1 Results Suven Pharmaceuticals Q2 Results Suven Pharmaceuticals Q3 Results Suven Pharmaceuticals Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
3,753.25+148.70(4.13%)
844.75+28.70(3.52%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)